1-3 of 3
powder dose form
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Glucagon Nasal Powder: A Promising Alternative to Intramuscular Glucagon in Youth With Type 1 Diabetes

Jennifer L. Sherr, Katrina J. Ruedy, Nicole C. Foster, Claude A. Piché, Hélène Dulude, Michael R. Rickels, William V. Tamborlane, Kathleen E. Bethin, Linda A. DiMeglio, Larry A. Fox, R. Paul Wadwa, Desmond A. Schatz, Brandon M. Nathan, Santica M. Marcovina, Emmanouil Rampakakis, Linyan Meng, Roy W. Beck, for the T1D Exchange Intranasal Glucagon Investigators
Journal: Diabetes Care
Diabetes Care 2016;39(4):555–562
DOI: https://doi.org/10.2337/dc15-1606
Published: 16 February 2016
View article
PDF
Includes: Supplementary data
Journal Articles

Efficacy and Safety of Technosphere Inhaled Insulin Compared With Technosphere Powder Placebo in Insulin-Naive Type 2 Diabetes Suboptimally Controlled With Oral Agents

Julio Rosenstock, MD, Richard Bergenstal, MD, Ralph A. DeFronzo, MD, Irl B. Hirsch, MD, David Klonoff, MD, Anders H. Boss, MD, MFPM, David Kramer, PHD, Richard Petrucci, MD, Wen Yu, MD, Brian Levy, MD, FACE, for the 0008 Study Group
Journal: Diabetes Care
Diabetes Care 2008;31(11):2177–2182
DOI: https://doi.org/10.2337/dc08-0315
Published: 01 November 2008
View article
PDF
Journal Articles

Dose Response of Inhaled Dry-Powder Insulin and Dose Equivalence to Subcutaneous Insulin Lispro

Klaus M. Rave, MD, Leszek Nosek, MD, Amparo de la Peña, PHD, Mary Seger, MS, Charles S. Ernest, II, BS, Lutz Heinemann, PHD, Richard P. Batycky, PHD, Douglas B. Muchmore, MD
Journal: Diabetes Care
Diabetes Care 2005;28(10):2400–2405
DOI: https://doi.org/10.2337/diacare.28.10.2400
Published: 01 October 2005
View article
PDF